Cathie Wood started to build up the position in Gilead Sciences in Q3 2017 and continued to invest until Q1 2018. Since then they sold 36.5 Thousand shares. The investor completely sold their stake between Q2 2018 and Q3 2018.
Avg closing price
Price range
Sold -28.9 Thousand shares
Q3 2018
Avg closing price
$75.52
Price range
$71.28
-
$78.92
Sold 20.6% shares (-7.53 Thousand shares)
Q2 2018
Avg closing price
$70.62
Price range
$64.88
-
$75.68
Increased shares by 54.1% (+12.8 Thousand shares)
Q1 2018
Avg closing price
$79.49
Price range
$72.84
-
$88.80
Increased shares by 275.5% (+17.4 Thousand shares)
Q4 2017